Effects of Frailty Status on Hospitalization Risk and Healthcare Costs among Patients Undergoing Maintenance Haemodialysis: A Retrospective Cohort Study
This retrospective cohort study of 738 maintenance haemodialysis patients in East China demonstrates that pre-frailty and frailty are independently associated with significantly increased frequencies and costs of all-cause hospitalizations, revealing a clear dose-response relationship that underscores the need for early frailty detection to reduce healthcare burdens.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For millions of people around the world, the kidneys have stopped working, leaving the body unable to filter waste and excess fluid from the blood. To stay alive, these patients undergo a treatment called maintenance haemodialysis, where a machine acts as an artificial kidney, cleaning the blood several times a week. While this life-saving procedure keeps the body functioning, it places a heavy, constant strain on the entire system. Over time, many of these patients develop a condition known as frailty. This is not simply about being weak or tired; it is a specific medical state where the body loses its reserve power. A frail person has less ability to handle stress, such as an infection or a minor injury, and is much more likely to suffer serious setbacks like falls, confusion, or death. While doctors have long known that frailty is common among dialysis patients, a critical question remained unanswered: how does this physical decline actually change the day-to-day reality of their healthcare, specifically regarding how often they end up in the hospital and how much it costs to treat them?
A team of researchers at the First Affiliated Hospital of Zhejiang University in China set out to answer this question by looking back at the records of nearly 740 patients undergoing dialysis. They wanted to see if the level of frailty a patient had at the start of the study could predict their future hospital visits and medical bills. To do this, the doctors used a well-established method to measure frailty, checking for five specific signs: unintentional weight loss, slow walking speed, weak grip strength, low energy levels, and a feeling of exhaustion. Based on how many of these signs a patient showed, the researchers sorted them into three groups: those who were not frail, those who were "pre-frail" (showing one or two signs), and those who were fully frail (showing three or more). The team then followed these patients for several years, tracking every time they were admitted to the hospital and calculating the total cost of those stays.
The results painted a clear and striking picture of a direct link between physical weakness and healthcare burden. Patients who were classified as pre-frail were already visiting the hospital significantly more often than those who were not frail. The data showed that pre-frail patients had about one and a half times as many hospital admissions. For those who were fully frail, the situation was even more severe; they were hospitalized roughly two and a half times as often as the non-frail group. This pattern held true even after the researchers accounted for other factors like age, gender, how long the patient had been on dialysis, and whether they had other conditions like diabetes or high blood pressure. The study also looked at the financial side of this equation. When comparing costs, the researchers found that pre-frail patients incurred an average of 5,354 US dollars more in hospitalization costs than their non-frail counterparts. For the fully frail patients, that extra cost jumped to 15,400 US dollars. This demonstrated a steady, dose-response relationship: as frailty increased, the number of hospital visits and the money spent on care rose in step.
The researchers were careful to consider other possibilities that might explain these numbers. They checked if the higher costs were simply because frail patients were older or had more severe kidney disease, but the data showed that frailty itself was an independent driver of these outcomes. Even when accounting for the fact that some patients might pass away before they could be hospitalized again—a factor that can sometimes skew statistics—the link between frailty and frequent, expensive hospital stays remained strong. The study also highlighted that the risk begins to rise early; patients in the pre-frail stage, who might seem only slightly weaker than others, were already facing significantly higher medical usage and costs. This suggests that the financial and physical toll of frailty starts accumulating long before a patient reaches the most severe stage.
These findings offer a new perspective on how to care for this vulnerable group. The research indicates that frailty is not just a personal health struggle but a major factor in the broader healthcare system, driving up both the frequency of hospital visits and the associated expenses. The authors suggest that identifying patients who are becoming pre-frail could be a crucial opportunity for intervention. By addressing these early signs through better nutrition, exercise, and support, it may be possible to slow the progression of frailty, keep patients out of the hospital more often, and reduce the substantial economic burden on families and healthcare systems. The study concludes that paying close attention to the physical strength and resilience of dialysis patients is essential, not only for their quality of life but also for the sustainability of the care they receive.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.